Trial Profile

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 02 Aug 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sunitinib (Primary)
Indications Solid tumours
Focus Registrational; Therapeutic Use
Sponsors Pfizer; Pfizer Global Research and Development

Most Recent Events

10 Jan 2012 Actual patient number changed from 310 to 313 as reported by ClinicalTrials.gov.
16 Dec 2011 Actual patient number is 310 as reported by ClinicalTrials.gov.
16 Dec 2011 Actual end date Dec 2011 added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com